Utilisation of biologicals in inflammatory bowel disease in Slovenia
Utilisation of biologicals in inflammatory bowel disease in Slovenia – report from UR-CARE registry for the year 2022
Utilisation of biologicals in inflammatory bowel disease in Slovenia – report from UR-CARE registry for the year 2022
In the last few decades, the incidence of inflammatory bowel disease (IBD) has increased. For some time IBD was known as a disease of the Western world, however, more recent data suggest a rapid increase in IBD incidence in the Eastern part of the world. This is most likely related to industrialisation and the adoption of Westernised diet and lifestyle in the East
Ulcerative colitis is a subtype of inflammatory bowel disease. This lifelong condition is characterized by inflamed colonic mucosa. Clinically it manifests with flares and remissions. Disease incidence increased in the last 20 years. The condition is more prevalent in the northern, more industrialized parts of the world.
Slovenian Association of
Gastroenterology and Hepatology
Zdraviliški trg 9
3250 Rogaška Slatina, Slovenia, EU
Web Design and Development by Studio N
© 2024 SAGH ⋅ All Rights Reserved.